Henry Schein
Henry Schein, Inc., a leading global provider of healthcare products and services, is headquartered in the United States. Founded in 1932, the company has established a strong presence in the dental, medical, and veterinary sectors, serving healthcare professionals across North America, Europe, and Asia. With a diverse portfolio that includes dental supplies, medical equipment, and practice management software, Henry Schein is renowned for its commitment to innovation and customer service. The company has achieved significant milestones, including its recognition as one of the Fortune 500 and its consistent ranking among the top healthcare distributors globally. Henry Schein's unique approach combines comprehensive product offerings with tailored solutions, making it a trusted partner for healthcare providers seeking to enhance patient care and operational efficiency.
DitchCarbon Score
How does Henry Schein's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Henry Schein's score of 66 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Henry Schein's reported carbon emissions
In 2023, Henry Schein, Inc. reported total greenhouse gas emissions of approximately 82481 tonnes CO2e from Scope 1 and 2 combined, with Scope 1 emissions at about 58304 tonnes CO2e and Scope 2 emissions at approximately 24177 tonnes CO2e. The company’s Scope 3 emissions were significantly higher, totalling about 776259 tonnes CO2e, primarily driven by purchased goods and services, which accounted for approximately 513618 tonnes CO2e. Henry Schein has set ambitious climate commitments, aiming to achieve net-zero emissions across its value chain by 2050. The company has established near-term targets to reduce absolute Scope 1 emissions by 42% by 2030 from a 2022 baseline and to increase its sourcing of renewable electricity from 0% in 2022 to 100% by 2030. Additionally, it aims to reduce Scope 3 emissions by 51.6% per million USD value added by 2030 and by 97% by 2050, also from a 2022 baseline. These targets are aligned with the Science-Based Targets initiative (SBTi) and reflect Henry Schein's commitment to sustainable practices within the healthcare sector. The company’s long-term goal includes a 90% reduction in Scope 1 emissions by 2050, further demonstrating its dedication to addressing climate change and reducing its carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 48,846,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Henry Schein is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
